CROs/Service Providers

Health Decisions creates ‘fixed-price trial’ model to incentivize CRO performance and speed timelines

Monday, June 27, 2011 08:03 AM

Since CROs began conducting trials for drug sponsors, there has been a lot of quibbling about cost. CROs claim to do the work more quickly, efficiently and inexpensively. But many sponsors have had the opposite experience, saying CROs don’t accomplish recruitment goals and keep extending the trial timelines to do so, adding to the sponsor’s costs. Some claim not all of the data is collected properly, taking months to then clean the data, for which sponsors are charged.

More... »

Five European CROs merge to form NEOX Europe

Friday, June 24, 2011 10:40 AM

Five independent CROs with operations stretching from Eastern to Western Europe have grouped together to form a new entity that will “act as one team and one company,” according to a report from PharmaTimes.

More... »

Sanofi teams up with Medco Health Solutions, UBC

Friday, June 24, 2011 10:29 AM

Sanofi is looking for more ‘real-world’ insight into its drug development and product lifecycle strategies by teaming up with pharmacy benefit manager Medco Health Solutions to help deliver value propositions that can withstand tough scrutiny from regulators and payers, reports PharmaTimes.

More... »

UBC launches Bracket division in a restructuring aimed at attracting CROs in need of services

Monday, June 20, 2011 07:55 AM

The restructuring of the pharmaceutical industry has not just caused CROs to scramble to win large strategic-partnership contracts from big pharma—it has also caused the parts of the industry that serve CROs to scramble for deals with the CROs that have won those big contracts.

More... »

Omnicare re-brands as Theorem Clinical Research

Thursday, June 16, 2011 10:29 AM

CRO Omnicare Clinical Research, based in King of Prussia, Penn., has re-branded the company under the name Theorem Clinical Research. The brand launch marks the final step in the CRO's separation from its former parent company in a deal that was finalized this spring.

More... »

Quintiles invests in Swiss biotech Kareus

Tuesday, June 14, 2011 01:54 PM

In further evidence of a shift toward more fundamental risk-sharing in drug development between biopharmaceutical companies and CROs, Quintiles is making a significant investment in Swiss biotech Kareus Therapeutics as part of a broad strategic alliance to move two of Kareus’ pre-clinical programs through clinical trials, according to PharmaTimes.

More... »

inVentiv Health completes i3 acquisition

Monday, June 13, 2011 09:56 AM

inVentiv Health has completed the acquisition of CRO i3. i3, previously owned by Ingenix, a UnitedHealth Group company.

More... »

Strategic partnerships: a good deal for CROs, or just a cost-cutting measure by big pharma?

Monday, June 13, 2011 08:01 AM

Strategic partnerships with the top 20 pharma companies are what most sizable CROs dream of these days.

More... »

Russia approves 95 new clinical trials in first quarter

Monday, June 6, 2011 03:02 PM

The Ministry of Health and Social Development of the Russian Federation (MoH) approved 95 new clinical trials of all types including local studies during the first quarter of 2011, 29% less than the year-ago quarter, according to a quarterly analytical report produced by Moscow-based CRO Synergy Research Group (SynRG).

More... »

Pfizer chooses Icon and Parexel as its two strategic outsourcing partners in 5-year deals

Monday, June 6, 2011 10:23 AM

Strategic partnerships with large pharma recently have become the holy grail among CROs. And two have been awarded by Pfizer, the largest drug maker in the world.

More... »